AI-Enhanced Medication Management for Acute Kidney Injury in Critical Care Settings
KIDNEYS · 26.01.2026 · 15 (1) · 212-220
DOI: 10.65327/kidneys.v15i1.611 ↗Kurz gefasst
Fachartikel in der Zeitschrift KIDNEYS, online erschienen am 26.01.2026. Verfasst von Dr Naveen Angadi und 5 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Acute kidney injury (AKI) is a frequent complication in critically ill patients and is often exacerbated by inappropriate medication dosing and exposure to nephrotoxic drugs. Rapid renal function changes and high medication burden in the intensive care unit (ICU) make renal-safe prescribing challenging. Artificial intelligence (AI)-assisted clinical decision support systems may aid medication optimisation during AKI.
Objective
To evaluate the association between AI-assisted medication review and renal dose appropriateness in critically ill patients with AKI, and to assess AKI progression and renal recovery during ICU admission.
Methods
A single-centre observational study was conducted in an adult ICU. Adult patients diagnosed with AKI using the Kidney Disease: Improving Global Outcomes (KDIGO) criteria and receiving at least one medication were included. Renal function was monitored using serum creatinine and urine output. Medications were assessed for renal dose appropriateness. An AI-assisted decision support tool provided dosing and nephrotoxicity recommendations without autonomous prescribing during routine clinical care settings.
Results
Patients had a mean age of 63 ± 12 years and received multiple medications during AKI. Renal dose appropriateness improved from 66% to 85% following AI-assisted review. Renal function improved in 44% of patients, while 23% experienced worsening AKI.
Conclusions
AI-assisted medication review was associated with improved renal-safe prescribing in critically ill patients with AKI, supporting its role as a clinician-centred adjunct in intensive care.
Zitieren
APA
Angadi, D. N., Kareliya, D. H., Thaker, D. U., Arya, B., Ganeshbala, D. A., & Medidha, R. (2026). AI-Enhanced Medication Management for Acute Kidney Injury in Critical Care Settings. KIDNEYS, 15(1), 212-220. https://doi.org/10.65327/kidneys.v15i1.611
Vancouver
Angadi DN, Kareliya DH, Thaker DU, Arya B, Ganeshbala DA, Medidha R. AI-Enhanced Medication Management for Acute Kidney Injury in Critical Care Settings. KIDNEYS. 2026;15(1):212-220. doi:10.65327/kidneys.v15i1.611
BibTeX
@article{Angadi2026,
author = {Angadi, Dr Naveen and Kareliya, Dr Hiten and Thaker, Dr Udgeeth and Arya, Bhupal and Ganeshbala, Dr. A. and Medidha, Rani},
title = {AI-Enhanced Medication Management for Acute Kidney Injury in Critical Care Settings},
journal = {KIDNEYS},
year = {2026},
volume = {15},
number = {1},
pages = {212--220},
doi = {10.65327/kidneys.v15i1.611}
}
EUVIMED